Characterization of printed PLA scaffolds for bone tissue engineering
Source abstract
Abstract
Abstract Autografts remain the gold standard for orthopedic transplantations. However, to overcome its limitations, bone tissue engineering proposes new strategies. This includes the development of new biomaterials such as synthetic polymers, to serve as scaffold for tissue production. The objective of this present study was to produce poly(lactic) acid (PLA) scaffolds of different pore size using fused deposition modeling (FDM) technique and to evaluate their physicochemical and biological properties. Structural, chemical, mechanical, and biological characterizations were performed. We successfully fabricated scaffolds of three different pore sizes. However, the pore dimensions were slightly smaller than expected. We found that the 3D printing process induced decreases in both, PLA molecular weight and degradation temperatures, but did not change the semicrystalline structure of the polymer. We did not observe any effect of pore size on the mechanical properties of produced scaffolds. After the sterilization by γ irradiation, scaffolds did not exhibit any cytotoxicity towards human bone marrow stromal cells (HBMSC). Finally, after three and seven days of culture, HBMSC showed high viability and homogenous distribution irrespective of pore size. Thus, these results suggest that FDM technology is a fast and reproducible technique that can be used to fabricate tridimensional custom‐made scaffolds for tissue engineering. © 2017 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 106A: 887–894, 2018.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Bone Tissue Engineering Materials · biodegradable polymer synthesis and properties · Additive Manufacturing and 3D Printing Technologies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Univ. Bordeaux, INSERM, Tissue Bioengineering, U1026 Bordeaux 33076 France
Univ. Bordeaux, INSERM , Tissue Bioengineering, U1026, CHU Bordeaux, Services d'Odontologie et de Santé Buccale Bordeaux 33076 France
Faculty of Technical Sciences, University of Novi Sad Serbia
Univ. Bordeaux, IPB‐ENSCBP, CNRS, Laboratoire de Chimie des Polymères Organiques, UMR5629 Pessac 33607 France
Univ. Bordeaux, Institut Bergonié, INSERM, ACTION, U1218 Bordeaux 33076 France
Funding
Agence Nationale de la Recherche
References (38)
Show source-provided references
1. 10.1016/j.actbio.2016.06.03210.1016/j.actbio.2016.06.032 ↗
2. 10.1016/S0278-2391(96)90257-810.1016/S0278-2391(96)90257-8 ↗
3. 10.1006/mthe.1999.000310.1006/mthe.1999.0003 ↗
4. 10.1016/j.biomaterials.2010.09.03510.1016/j.biomaterials.2010.09.035 ↗
5. 10.1016/j.actbio.2006.07.00810.1016/j.actbio.2006.07.008 ↗
6. 10.1016/j.dental.2011.09.01010.1016/j.dental.2011.09.010 ↗
7. 10.1007/s00449-010-0499-210.1007/s00449-010-0499-2 ↗
8. 10.1021/acsami.6b1179310.1021/acsami.6b11793 ↗
9. 10.1080/14686996.2016.114553210.1080/14686996.2016.1145532 ↗
10. 10.1089/ten.tec.2011.038210.1089/ten.tec.2011.0382 ↗
11. 10.1371/journal.pone.008428710.1371/journal.pone.0084287 ↗
12. 10.1007/s10856-017-5887-610.1007/s10856-017-5887-6 ↗
13. 10.1088/1748-6041/11/1/01501110.1088/1748-6041/11/1/015011 ↗
14. 10.1016/j.msec.2014.01.00310.1016/j.msec.2014.01.003 ↗
15. Skin cell culture on an ear‐shaped scaffold created by fused deposition modelling
16. 10.1016/j.actbio.2016.02.00410.1016/j.actbio.2016.02.004 ↗
17. 10.1016/j.archoralbio.2017.06.01810.1016/j.archoralbio.2017.06.018 ↗
18. 10.1080/09205063.2017.135467410.1080/09205063.2017.1354674 ↗
19. 10.1186/s13036-015-0001-410.1186/s13036-015-0001-4 ↗
20. 10.1108/1355254051058945810.1108/13552540510589458 ↗
21. 10.1016/j.actbio.2013.10.03510.1016/j.actbio.2013.10.035 ↗
22. 10.1016/j.addr.2016.06.01810.1016/j.addr.2016.06.018 ↗
23. 10.1016/j.jmbbm.2015.11.03610.1016/j.jmbbm.2015.11.036 ↗
24. 10.1016/S0141-3910(97)00148-110.1016/S0141-3910(97)00148-1 ↗
25. 10.3144/expresspolymlett.2015.4210.3144/expresspolymlett.2015.42 ↗
26. Poly‐epsilon‐caprolactone/gel hybrid scaffolds for cartilage tissue engineering10.1002/jbm.a.32521 ↗
27. 10.1016/j.actbio.2010.06.02510.1016/j.actbio.2010.06.025 ↗
28. 10.1016/j.jmbbm.2013.01.01210.1016/j.jmbbm.2013.01.012 ↗
29. 10.1007/BF0263142610.1007/BF02631426 ↗
30. 10.1016/j.actbio.2013.05.02510.1016/j.actbio.2013.05.025 ↗
31. 10.1038/srep2170410.1038/srep21704 ↗
32. 10.1002/term.55510.1002/term.555 ↗
33. 10.3390/ijms1503364010.3390/ijms15033640 ↗
34. 10.1016/j.addr.2016.06.01210.1016/j.addr.2016.06.012 ↗
35. [Biocompatibility of porous poly lactic acid/bone matrix gelatin composite biomaterials for bone repair]
36. 10.1016/j.msec.2016.03.01810.1016/j.msec.2016.03.018 ↗
37. The use of total human bone marrow fraction in a direct three‐dimensional expansion approach for bone tissue engineering applications: focus on angiogenesis and osteogenesis. Tissue Eng
38. 10.1016/j.actbio.2015.10.00310.1016/j.actbio.2015.10.003 ↗